Reprise Biomedical is a leading brand focused on the development and commercialization of biologic medical devices. They specialize in utilizing a proprietary perfusion decellularization process, which delivers superior clinical outcomes in a wide range of surgical procedures. Founded in 2019 as a spin-out from Miromatrix Medical and licensed from the University of Minnesota, Reprise Biomedical has quickly gained recognition for their innovative products and services.

Their product lineup includes Miro3D, MiroDerm, and MiroFlex, offering cutting-edge biologic medical devices that meet the highest standards of quality and performance. By leveraging their expertise and advanced technology, Reprise is able to provide surgeons and their patients with exceptional clinical outcomes. With a team of experienced professionals in medical device management, Reprise Biomedical is guided by a Board of Directors with a proven track record of business success.

The company's culture emphasizes individual empowerment and responsibility, ensuring that their products prioritize the clinical outcomes of physicians and the well-being of their patients. For more information about Reprise Biomedical and their groundbreaking solutions, visit their website or contact them via phone or email